The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Sanofi CEO Chris Viehbacher Comments on Results for Q2 2012

Thursday, July 26, 2012

Sanofi CEO Chris Viehbacher Comments on Results for Q2 201201:49 EDT Thursday, July 26, 2012 PARIS (Business Wire) -- Sanofi, a global and diversified healthcare leader, reports results for the second quarter of 2012. CEO Chris Viehbacher comments on Q2 results and outlook. Click to watch the video:http://www.eurobusinessmedia.com/Sanofi-CEO-Chris-Viehbacher-comments-on-results-for-Q2-2012?utm_source=ceo-direct&utm_medium=bw Topics covered in the interview include: - Q2 2012 Results- Patent Cliff- Emerging Markets- Diabetes- Genzyme- Vaccines- PCSK9- R&D Transformation- Guidance About Sanofi Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Company website: www.sanofi.com SanofiInvestor Relations:Sébastien Martel, +33 1 53 77 45 45IR@sanofi.comorMedia Relations:+33 1 53 77 45 02MR@sanofi.com